Quest Diagnostics Declares Quarterly Cash Dividend
Rhea-AI Summary
Quest Diagnostics (NYSE: DGX) announced that its Board declared a quarterly cash dividend of $0.80 per share. The dividend is payable on January 28, 2026 to shareholders of record as of January 13, 2026. This provides a scheduled cash return to common shareholders and sets the key dates for eligibility and payment.
Positive
- $0.80 per share quarterly dividend declared
- Dividend payable Jan 28, 2026
- Record date set as Jan 13, 2026 for eligibility
Negative
- Declared dividend creates a near-term cash outflow of $0.80 per share
News Market Reaction 1 Alert
On the day this news was published, DGX declined 1.06%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-declares-quarterly-cash-dividend-302612105.html
SOURCE Quest Diagnostics